Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.66)
# 3,427
Out of 5,111 analysts
57
Total ratings
45.95%
Success rate
-5.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Overweight | $350 → $360 | $291.51 | +23.49% | 6 | Nov 7, 2025 | |
| ABT Abbott Laboratories | Maintains: Overweight | $142 → $146 | $128.47 | +13.65% | 9 | Oct 16, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Equal-Weight | $172 → $184 | $200.09 | -8.04% | 5 | Aug 8, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $15.92 | +25.63% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $22.11 | +270.87% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $126.72 | +95.71% | 1 | Jul 29, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $559.52 | -39.41% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.71 | +111.27% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $2.55 | +958.82% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $92.43 | +20.09% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $65.73 | +118.70% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $111.73 | -49.88% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $86.41 | -14.36% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $83.38 | -8.05% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $12.97 | +593.91% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $86.50 | - | 1 | Dec 12, 2019 |
Insulet
Nov 7, 2025
Maintains: Overweight
Price Target: $350 → $360
Current: $291.51
Upside: +23.49%
Abbott Laboratories
Oct 16, 2025
Maintains: Overweight
Price Target: $142 → $146
Current: $128.47
Upside: +13.65%
Becton, Dickinson and Company
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $172 → $184
Current: $200.09
Upside: -8.04%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $15.92
Upside: +25.63%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $22.11
Upside: +270.87%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $126.72
Upside: +95.71%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $559.52
Upside: -39.41%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.71
Upside: +111.27%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $2.55
Upside: +958.82%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $92.43
Upside: +20.09%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $65.73
Upside: +118.70%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $111.73
Upside: -49.88%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $86.41
Upside: -14.36%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $83.38
Upside: -8.05%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $12.97
Upside: +593.91%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $86.50
Upside: -